173 related articles for article (PubMed ID: 24611168)
1. Infectious disease: Beating the big three.
Bourzac K
Nature; 2014 Mar; 507(7490):S4-7. PubMed ID: 24611168
[No Abstract] [Full Text] [Related]
2. A 2020 vision for vaccines against HIV, tuberculosis and malaria.
Rappuoli R; Aderem A
Nature; 2011 May; 473(7348):463-9. PubMed ID: 21614073
[TBL] [Abstract][Full Text] [Related]
3. The RV144 Thai HIV vaccine trial.
Plotkin SA
Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337
[No Abstract] [Full Text] [Related]
4. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
Mamotte N; Wassenaar D; Koen J; Essack Z
BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
[TBL] [Abstract][Full Text] [Related]
5. The 2017 Keystone Symposium on HIV Vaccines.
Cottrell CA; Ward AB
Hum Vaccin Immunother; 2017 Oct; 13(10):2348-2351. PubMed ID: 28786733
[No Abstract] [Full Text] [Related]
6. AIDS research. Novel antibody response may explain HIV vaccine success.
Cohen J
Science; 2011 Sep; 333(6049):1560. PubMed ID: 21921167
[No Abstract] [Full Text] [Related]
7. Infectious disease. An enterprising time for HIV vaccine research.
Cohen J
Science; 2012 Sep; 337(6101):1446. PubMed ID: 22997300
[No Abstract] [Full Text] [Related]
8. RV144: old vs. new.
Weiner DB
Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335
[No Abstract] [Full Text] [Related]
9. Combined efforts in immunology and vaccinology will lead to effective vaccines against HIV, tuberculosis and malaria.
Chiodi F; Kaufmann SH
J Intern Med; 2014 May; 275(5):442-3. PubMed ID: 24635534
[No Abstract] [Full Text] [Related]
10. HIV/AIDS: vaccines and alternate strategies for treatment and prevention.
Voronin Y; Phogat S
Ann N Y Acad Sci; 2010 Sep; 1205 Suppl 1():E1-9. PubMed ID: 20860672
[TBL] [Abstract][Full Text] [Related]
11. HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem.
Koff WC
Vaccine; 2012 Jun; 30(29):4310-5. PubMed ID: 22100891
[TBL] [Abstract][Full Text] [Related]
12. HIV Vaccines: One Step Closer.
Low MSY; Tarlinton D
Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424
[TBL] [Abstract][Full Text] [Related]
13. Novel tuberculosis vaccines on the horizon.
Parida SK; Kaufmann SH
Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
[TBL] [Abstract][Full Text] [Related]
14. In pursuit of an HIV vaccine: an interview with Andrew McMichael.
McMichael AJ
BMC Biol; 2013 May; 11():60. PubMed ID: 23692824
[No Abstract] [Full Text] [Related]
15. The challenges of an HIV vaccine enterprise.
Zinkernagel RM
Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14988536
[No Abstract] [Full Text] [Related]
16. Statistical methods for the analysis of clinical trials data containing many zeros: An application in vaccine development.
Callegaro A; Kassapian M; Zahaf T; Tibaldi F
Stat Methods Med Res; 2016 Dec; 25(6):2811-2826. PubMed ID: 24845724
[TBL] [Abstract][Full Text] [Related]
17. HIV vaccine development--improving on natural immunity.
Johnston MI; Fauci AS
N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447
[No Abstract] [Full Text] [Related]
18. In vivo protection by broadly neutralizing HIV antibodies.
van Gils MJ; Sanders RW
Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020
[TBL] [Abstract][Full Text] [Related]
19. Dancing with an escape artist.
Deweerdt S
Nature; 2010 Jul; 466(7304):S6-7. PubMed ID: 20631705
[No Abstract] [Full Text] [Related]
20. Cell-mediated immunity needed for TB vaccine.
Indian J Med Sci; 1998 Nov; 52(11):521-2. PubMed ID: 10218297
[No Abstract] [Full Text] [Related]
[Next] [New Search]
